Antifungal Drug Market by Drug Type (Echinocandins, Azoles, Ployenes, Allylamines and Others) and by Dosage Form Forecast by 2021

Antifungal Drug Market by Drug Type (Echinocandins, Azoles, Ployenes, Allylamines and Others) and by Dosage Form Forecast by 2021

Comments Off on Antifungal Drug Market by Drug Type (Echinocandins, Azoles, Ployenes, Allylamines and Others) and by Dosage Form Forecast by 2021

According to the report, the global antifungal drug market accounted for around USD 11.30 billion in 2015 and is expected to reach approximately USD 14.10 billion by 2021, growing at a CAGR of around 3.6% between 2015 and 2021. Fungi are quite different from bacteria in physical characteristics like size, cellular structure, and chemical composition. Fungi are considered as a “higher beings” when it is compared with bacteria, viruses, and another small micro-organism. It may contain one nucleus or multiple nuclei surrounded by a specific cell wall. However, fungi life cycle may vary from simple to complex and it may reproduce by both asexual and sexual reproduction. Because of the distinct feature, fungi are considered to be much more complex than bacteria. Fungi are also able to adjust and reproduce in abnormal environments such as mammalian tissue. In particular, yeasts is a class of fungi which readily adapts to the human environment and organisms such as Candida species are normal inhabitants of the skin, gastrointestinal tract, female genital tract and urine.

 

According to the report, the global antifungal drug market accounted for around USD 11.30 billion in 2015 and is expected to reach approximately USD 14.10 billion by 2021, growing at a CAGR of around 3.6% between 2015 and 2021.

Fungi are a diverse group of microorganisms that have modified themselves to remain alive in a wide array of environments. These environments may vary from the human body to discrete areas of nature. Fungi can produce diverse human infections ranging from superficial skin infections to internal organ invasion in the body. These viable infections usually happen due to decrease in natural human defenses/immune system or due to heavy exposure to the fungus. Selection of   therapies for treating fungal infections based on the type of infection or type of fungus involved in infection. Topical/superficial infections are usually treated with topical agents whereas peripheral infection is treated with systemic therapy.

Globally, antifungal drug market has been accelerated due to continuous rise in percentage of fungal infections specially the ringworm infection. Furthermore, lack of awareness coupled with self medication are considered as major key factors which are expected to promotes the growth of antifungal drug market. Moreover many lifestyle-related factors, such as sedentary lifestyle, eating junk food which may leads to weaken the immune system and thus promote the fungal growth. However, high penetration of conventional drugs is key restraining factor for the growth of anti-fungal drug market. Nonetheless, ongoing research and development in prevention and treatment of fungal infection like to bring growth avenues nearby future.

Global-Antifungal-Drug-Market

Based on drug type, the global market of antifungal drug is bifurcated into five types: echinocandins, azoles, ployenes, allylamines and others. Azoles are systemically acting antifungal drug which include fluconazole, itraconazole, ketoconazole, posaconazole and voriconazole. The echinocandins are lipopeptides derived from natural fungal fermentation products. They include anidulafungin, caspofungin and micafungin. Azole derivative was the leading derivatives in term of generating revenue in 2015 and this growth is expected to continue within the forecast period. The growth is attributed due to effective price and fungicidal properties of azole derivatives like ketokonazole, itaconazole etc.

Based on therapeutic indication, the global market of antifungal drug is bifurcated into four types: aspergillosis, dermatophytosis, candidiasis and others. The most commonly encountered fungal infections are those that affect the skin layers. Approximately 1-2% of the world’s population is affected by dermatophytoses (superficial fungal infections of the skin). Seborric dermatisis, ringworm infection, jock itch are the examples of various topical fungal infections.

Based on dosage form, the global market of antifungal drug is bifurcated into four types: powders, ointments, drugs and pastes. Over the counter antifungal drugs like clo-trimoxazole (sulphamethoxazole + trimethoprim) are available in powder, ointment form and can be easily obtained without doctor/physician prescriptions. Whereas, majority of the oral antifungal drugs are prescription based medicines and are available in various dosage forms such as tablets, capsules and suspensions. Powder, ointment is covering approximately more than 55% of antifungal drug market.

Based on geographies, the global market of antifungal drug is bifurcated into five types: North America, Europe, Asia Pacific, Latin America and Middle East and Africa. These segments are further bifurcated into the U.S., UK, Germany, France, China, Japan, India and Brazil. North America accounted for the largest share of the global antifungal market, followed by Europe. This growth is attributed due to rising awareness related to health care in this region. Moreover, antifungal drug market has huge opportunity in the emerging markets of Asia Pacific region due to increasing standard of living, large pool of patient in this region. The Asia-Pacific market is projected to grow at the highest CAGR during the forecast period, due to the rising incidence of fungal infection, increasing government support and growing upper middle-class population and rise in disposable income level in this region. Understanding the rising episodes of fungal infections in the country, the government employed various measures on its own including public private partnership (PPP). This development is largely responsible for propelling the Indian market of antifungal drug.

The report covers detailed competitive outlook including the market share and company profiles of the key participants operating in the global antifungal drug market include Asperqillus, Alternaria, Abbott Laboratories, Pfizer, Glaxosmithkline, Bayer Healthcare, Novartis, Sanofi-Aventis, Merck & Co., Kramer Laboratories, Enzon Pharmaceuticals, and Gilead.

  • Chapter 1. Introduction
    • 1.1. Report Description And Scope
    • 1.2. Research Scope
    • 1.3. Research Methodology
      • 1.3.1. Market Research Process
      • 1.3.2. Market Research Methodology
  • Chapter 2. Executive Summary
    • 2.1. Global Antifungal Drug Market, 2015 – 2021 (USD Billion)
    • 2.2. Global Antifungal Drug Market: Snapshot
  • Chapter 3. Antifungal Drug – Market Dynamics
    • 3.1. Introduction
    • 3.2. Value Chain Analysis
    • 3.3. Market Drivers
      • 3.3.1. Global Antifungal Drug Market Drivers: Impact Analysis
      • 3.3.2. Rapid Spread Of Fungal Infection
      • 3.3.3. Pandemicity Of Fungal Infection
    • 3.4. Market Restraints
      • 3.4.1. Global Antifungal Drug Market Restraints: Impact Analysis
      • 3.4.2. High Penetration Of Conventional Drugs
    • 3.5. Opportunities
      • 3.5.1. Covering Untapped Market
    • 3.6. Porter’s Five Forces Analysis
      • 3.6.1. Bargaining Power Of Suppliers
      • 3.6.2. Bargaining Power Of Buyers
      • 3.6.3. Threat From New Entrants
      • 3.6.4. Threat From New Substitutes
      • 3.6.5. Degree Of Competition
    • 3.7. Market Attractiveness Analysis
      • 3.7.1. Market Attractiveness Analysis, By Drug Type Segment
      • 3.7.2. Market Attractiveness Analysis, By Therapeutic Indication Segment
      • 3.7.3. Market Attractiveness Analysis, By Dosage Form Segment
      • 3.7.4. Market Attractiveness Analysis, By Regional Segment
  • Chapter 4. Global Antifungal Drug Market – Competitive Landscape
    • 4.1. Company Market Share, 2015 (Subject To Data Availability)
    • 4.2. Strategic Development
      • 4.2.1. Acquisitions & Mergers
      • 4.2.2. New Type Launch
      • 4.2.3. Agreements, Partnerships, Collaborations And Joint Ventures
      • 4.2.4. Research And Development, Regional Expansion
    • 4.3. Type Portfolio
  • Chapter 5. Global Antifungal Drug Market – Test Analysis
    • 5.1. Global Antifungal Drug Market: Test Overview
      • 5.1.1. Global Antifungal Drug Market Revenue Share, By Test , 2015 And 2021
    • 5.2. Echinocandins
      • 5.2.1. Global Echinocandins Testing Market, 2015 – 2021 (USD Billion)
    • 5.3. Azoles
      • 5.3.1. Global Azoles Market, 2015 – 2021 (USD Billion)
    • 5.4. Ployenes
      • 5.4.1. Global Ployenes Market, 2015 – 2021 (USD Billion)
    • 5.5. Allylamines
      • 5.5.1. Global Allylamines Market, 2015 – 2021 (USD Billion)
    • 5.6. Others
      • 5.6.1. Global Other Antifungal Drug Market, 2015 – 2021 (USD Billion)
  • Chapter 6. Global Antifungal Drug Market – Therapeutic Indication Analysis
    • 6.1. Global Antifungal Drug Market: Therapeutic Indication Segment Overview
      • 6.1.1. Global Antifungal Drug Market Revenue Share, By Therapeutic Indication, 2015 And 2021
    • 6.2. Aspergillosis
      • 6.2.1. Global Antifungal Drug Market For Aspergillosis, 2015 – 2021 (USD Billion)
    • 6.3. Dermatophytosis
      • 6.3.1. Global Antifungal Drug Market For Dermatophytosis, 2015 – 2021 (USD Billion)
    • 6.4. Candidiasis
      • 6.4.1. Global Antifungal Drug Market For Candidiasis, 2015 – 2021 (USD Billion)
    • 6.5. Others
      • 6.5.1. Global Antifungal Drug For Others Therapeutic Indication Market, 2015 – 2021 (USD Billion)
  • Chapter 7. Global Antifungal Drug Market – Dosage Form Analysis
    • 7.1. Global Antifungal Drug Market: Dosage Form Segment Overview
      • 7.1.1. Global Antifungal Drug Market Revenue Share, By Dosage Form, 2015 And 2021
    • 7.2. Powders
      • 7.2.1. Global Antifungal Drug Market For Powders, 2015 – 2021 (USD Billion)
    • 7.3. Ointment
      • 7.3.1. Global Antifungal Drug For Ointment Market, 2015 – 2021 (USD Billion)
    • 7.4. Drugs
      • 7.4.1. Global Antifungal Drug Market For Drugs, 2015 – 2021 (USD Billion)
    • 7.5. Paste
      • 7.5.1. Global Antifungal Drug For Paste Market, 2015 – 2021 (USD Billion)
  • Chapter 8. Global Antifungal Drug Market – Regional Segment Analysis
    • 8.1. Global Antifungal Drug Market: Regional Overview
      • 8.1.1. Global Antifungal Drug Market Revenue Share, By Region, 2015 And 2021
    • 8.2. North America
      • 8.2.1. North America Antifungal Drug Market Revenue, By Drug Type , 2015 – 2021 , (USD Billion)
      • 8.2.2. North America Antifungal Drug Market Revenue, By Therapeutic Indication, 2015 – 2021 , (USD Billion)
      • 8.2.3. North America Antifungal Drug Market Revenue, By Dosage Form , 2015 – 2021 , (USD Billion)
      • 8.2.4. U.S.
        • 8.2.4.1. U.S. Antifungal Drug Market Revenue, By Drug Type , 2015 – 2021 (USD Billion)
      • 8.2.5. U.S.
        • 8.2.5.1. U.S. Antifungal Drug Market Revenue, By Therapeutic Indication, 2015 – 2021 (USD Billion)
      • 8.2.6. U.S.
        • 8.2.6.1. U.S. Antifungal Drug Market Revenue, By Dosage Form , 2015 – 2021 (USD Billion)
    • 8.3. Europe
      • 8.3.1. Europe Antifungal Drug Market Revenue, By Drug Type , 2015 – 2021 (USD Billion)
      • 8.3.2. Europe Antifungal Drug Market Revenue, By Therapeutic Indication, 2015 – 2021 (USD Billion)
      • 8.3.3. Europe Antifungal Drug Market Revenue, By Dosage Form , 2015 – 2021 (USD Billion)
      • 8.3.4. Germany
        • 8.3.4.1. Germany Antifungal Drug Market Revenue, By Drug Type , 2015 – 2021, (USD Billion)
        • 8.3.4.2. Germany Antifungal Drug Market Revenue, By Therapeutic Indication, 2015 – 2021, (USD Billion)
        • 8.3.4.3. Germany Antifungal Drug Market Revenue, By Dosage Form , 2015 – 2021, (USD Billion)
      • 8.3.5. France
        • 8.3.5.1. France Antifungal Drug Market Revenue, By Drug Type , 2015 – 2021, (USD Billion)
        • 8.3.5.2. France Antifungal Drug Market Revenue, By Therapeutic Indication, 2015 – 2021, (USD Billion)
        • 8.3.5.3. France Antifungal Drug Market Revenue, By Dosage Form , 2015 – 2021, (USD Billion)
      • 8.3.6. UK
        • 8.3.6.1. UK Antifungal Drug Market Revenue, By Drug Type , 2015 – 2021 (USD Billion)
        • 8.3.6.2. UK Antifungal Drug Market Revenue, By Therapeutic Indication, 2015 – 2021 (USD Billion)
        • 8.3.6.3. UK Antifungal Drug Market Revenue, By Dosage Form , 2015 – 2021 (USD Billion)
    • 8.4. Asia Pacific
      • 8.4.1. Asia Pacific Antifungal Drug Market Revenue, By Drug Type , 2015 – 2021 (USD Billion)
      • 8.4.2. Asia Pacific Antifungal Drug Market Revenue, By Therapeutic Indication, 2015 – 2021 (USD Billion)
      • 8.4.3. Asia Pacific Antifungal Drug Market Revenue, By Dosage Form , 2015 – 2021 (USD Billion)
      • 8.4.4. China
        • 8.4.4.1. China Antifungal Drug Market Revenue, By Drug Type , 2015 – 2021 (USD Billion)
        • 8.4.4.2. China Antifungal Drug Market Revenue, By Therapeutic Indication, 2015 – 2021 (USD Billion)
        • 8.4.4.3. China Antifungal Drug Market Revenue, By Dosage Form , 2015 – 2021 (USD Billion)
      • 8.4.5. Japan
        • 8.4.5.1. Japan Antifungal Drug Market Revenue, By Drug Type , 2015 – 2021 (USD Billion)
        • 8.4.5.2. Japan Antifungal Drug Market Revenue, By Therapeutic Indication, 2015 – 2021 (USD Billion)
        • 8.4.5.3. Japan Antifungal Drug Market Revenue, By Dosage Form , 2015 – 2021 (USD Billion)
      • 8.4.6. India
        • 8.4.6.1. India Antifungal Drug Market Revenue, By Drug Type , 2015 – 2021 (USD Billion)
        • 8.4.6.2. India Antifungal Drug Market Revenue, By Therapeutic Indication, 2015 – 2021 (USD Billion)
        • 8.4.6.3. India Antifungal Drug Market Revenue, By Dosage Form , 2015 – 2021 (USD Billion)
    • 8.5. Latin America
      • 8.5.1. Latin America Antifungal Drug Market Revenue, By Drug Type , 2015 – 2021 (USD Billion)
      • 8.5.2. Latin America Antifungal Drug Market Revenue, By Therapeutic Indication, 2015 – 2021 (USD Billion)
      • 8.5.3. Latin America Antifungal Drug Market Revenue, By Dosage Form , 2015 – 2021 (USD Billion)
      • 8.5.4. Brazil
        • 8.5.4.1. Brazil Antifungal Drug Market Revenue, By Drug Type , 2015 – 2021 (USD Billion)
        • 8.5.4.2. Brazil Antifungal Drug Market Revenue, By Therapeutic Indication, 2015 – 2021 (USD Billion)
        • 8.5.4.3. Brazil Antifungal Drug Market Revenue, By Dosage Form , 2015 – 2021 (USD Billion)
    • 8.6. Middle East And Africa
      • 8.6.1. Middle East And Africa Antifungal Drug Market Revenue, By Drug Type , 2015 – 2021 (USD Billion)
      • 8.6.2. Middle East And Africa Antifungal Drug Market Revenue, By Therapeutic Indication, 2015 – 2021 (USD Billion)
      • 8.6.3. Middle East And Africa Antifungal Drug Market Revenue, By Dosage Form , 2015 – 2021 (USD Billion)
  • Chapter 9. Company Profile
    • 9.1. Asperqillus
      • 9.1.1. Overview
      • 9.1.2. Financials
      • 9.1.3. Product Portfolio
      • 9.1.4. Business Strategy
      • 9.1.5. Recent Developments
    • 9.2. Alternaria
      • 9.2.1. Overview
      • 9.2.2. Financials
      • 9.2.3. Product Portfolio
      • 9.2.4. Business Strategy
      • 9.2.5. Recent Developments
    • 9.3. Abbott Laboratories
      • 9.3.1. Overview
      • 9.3.2. Financials
      • 9.3.3. Product Portfolio
      • 9.3.4. Business Strategy
      • 9.3.5. Recent Developments
    • 9.4. Pfizer
      • 9.4.1. Overview
      • 9.4.2. Financials
      • 9.4.3. Product Portfolio
      • 9.4.4. Business Strategy
      • 9.4.5. Recent Developments
    • 9.5. Glaxosmithkline
      • 9.5.1. Overview
      • 9.5.2. Financials
      • 9.5.3. Product Portfolio
      • 9.5.4. Business Strategy
      • 9.5.5. Recent Developments
    • 9.6. Bayer Healthcare
      • 9.6.1. Overview
      • 9.6.2. Financials
      • 9.6.3. Product Portfolio
      • 9.6.4. Business Strategy
      • 9.6.5. Recent Developments
    • 9.7. Novartis
      • 9.7.1. Overview
      • 9.7.2. Financials
      • 9.7.3. Product Portfolio
      • 9.7.4. Business Strategy
      • 9.7.5. Recent Developments
    • 9.8. Sanofi-Aventis
      • 9.8.1. Overview
      • 9.8.2. Financials
      • 9.8.3. Product Portfolio
      • 9.8.4. Business Strategy
      • 9.8.5. Recent Developments
    • 9.9. Merck & Co.
      • 9.9.1. Overview
      • 9.9.2. Financials
      • 9.9.3. Product Portfolio
      • 9.9.4. Business Strategy
      • 9.9.5. Recent Developments
    • 9.10. Kramer Laboratories
      • 9.10.1. Overview
      • 9.10.2. Financials
      • 9.10.3. Product Portfolio
      • 9.10.4. Business Strategy
      • 9.10.5. Recent Developments

List of Figures

1. Market Research Process
2. Market Research Methodology
3. Global Antifungal Drug Market Revenue, 2015 – 2021 (USD Billion)
4. Porter’s Five Forces Analysis
5. Antifungal Drug : Market Attractiveness Analysis, By Drug Type Segment
6. Antifungal Drug : Market Attractiveness Analysis, By Therapeutic Indication Segment
7. Antifungal Drug : Market Attractiveness Analysis, By Dosage Form Segment
8. Antifungal Drug : Market Attractiveness Analysis, By Regional Segment
9. Company Market Share Analysis, 2015 And 2021
10. Global Antifungal Drug Market Revenue Share By Drug Type , 2015 And 2021
11. Ployenes Market, 2015 – 2021, (USD Billion)
12. Echinocandins Market, 2015 – 2021, (USD Billion)
13. Azoles Market, 2015 – 2021, (USD Billion)
14. Allylamines Market, 2015 – 2021, (USD Billion)
15. Other Antifungal Drug Market, 2015 – 2021, (USD Billion)
16. Global Antifungal Drug Market Revenue Share By Therapeutic Indication, 2015 And 2021
17. Antifungal Drug Market for Aspergillosis, 2015 – 2021, (USD Billion)
18. Antifungal Drug Market for Dermatophytosis, 2015 – 2021, (USD Billion)
19. Antifungal Drug Market for Candidiasis, 2015 – 2021, (USD Billion)
20. Antifungal Drug Market for Other Therapeutic Indication, 2015 – 2021, (USD Billion)
21. Global Antifungal Drug Market Revenue Share By Dosage Form, 2015 And 2021
22. Antifungal Drug Market for Powder, 2015 – 2021, (USD Billion)
23. Antifungal Drug Market for Ointment, 2015 – 2021, (USD Billion)
24. Antifungal Drug Market for Drug, 2015 – 2021, (USD Billion)
25. Antifungal Drug Market for Paste, 2015 – 2021, (USD Billion)
26. Global Antifungal Drug Market Share, By Region, 2015 – 2021
27. North America Antifungal Drug Market, 2015 – 2021, (USD Billion)
28. U.S. Antifungal Drug Market, 2015 – 2021, (USD Billion)
29. Europe Antifungal Drug Market, 2015 – 2021, (USD Billion)
30. UK Antifungal Drug Market, 2015 – 2021, (USD Billion)
31. France Antifungal Drug Market, 2015 – 2021, (USD Billion)
32. Germany Antifungal Drug Market, 2015 – 2021, (USD Billion)
33. Asia Pacific Antifungal Drug Market, 2015 – 2021, (USD Billion)
34. China Antifungal Drug Market, 2015 – 2021, (USD Billion)
35. Japan Antifungal Drug Market, 2015 – 2021, (USD Billion)
36. India Antifungal Drug Market, 2015 – 2021, (USD Billion)
37. Latin America Antifungal Drug Market, 2015-2021, (USD Billion)
38. Brazil Antifungal Drug Market, 2015 – 2021, (USD Billion)
39. Middle East & Africa Antifungal Drug Market, 2015 – 2021, (USD Billion)


List of Tables

1. Antifungal Drug  Market: Market Snapshot
2. Drivers Of Global Antifungal Drug  Market: Impact Analysis
3. Restraints Of Global Antifungal Drug  Market: Impact Analysis
4. North America Antifungal Drug Market Revenue, By Drug Type , 2015 – 2021(USD Billion)
5. North America Antifungal Drug Market Revenue, By Therapeutic Indication, 2015 – 2021(USD Billion)
6. North America Antifungal Drug Market Revenue, By Dosage Form , 2015 – 2021(USD Billion)
7. US Antifungal Drug Market Revenue, By Drug Type , 2015 – 2021(USD Billion)
8. US Antifungal Drug Market Revenue, By Therapeutic Indication, 2015 – 2021(USD Billion)
9. US Antifungal Drug Market Revenue, By Dosage Form , 2015 – 2021(USD Billion)
10. Europe Antifungal Drug Market Revenue, By Drug Type , 2015 – 2021(USD Billion)
11. Europe Antifungal Drug  Market Revenue, By Therapeutic Indication, 2015 – 2021(USD Billion)
12. Europe Antifungal Drug Market Revenue, By Dosage Form, 2015 – 2021(USD Billion)
13. UK Antifungal Drug Market Revenue, By Drug Type, 2015 – 2021(USD Billion)
14. UK Antifungal Drug Market Revenue, By Therapeutic Indication, 2015 – 2021(USD Billion)
15. UK Antifungal Drug Market Revenue, By Dosage Form , 2015 – 2021(USD Billion)
16. France Antifungal Drug Market Revenue, By Drug Type , 2015 – 2021(USD Billion)
17. France Antifungal Drug Market Revenue, By Therapeutic Indication, 2015 – 2021(USD Billion)
18. France Antifungal Drug Market Revenue, By Dosage Form , 2015 – 2021(USD Billion)
19. Germany Antifungal Drug Market Revenue, By Drug Type , 2015 – 2021(USD Billion)
20. Germany Antifungal Drug Market Revenue, By Therapeutic Indication, 2015 – 2021(USD Billion)
21. Germany Antifungal Drug Market Revenue, By Dosage Form , 2015 – 2021(USD Billion)
22. Asia Pacific Antifungal Drug Market Revenue, By Drug Type 2015 – 2021(USD Billion)
23. Asia Pacific Antifungal Drug Market Revenue, By Therapeutic Indication 2015 – 2021(USD Billion)
24. Asia Pacific Antifungal Drug Market Revenue, By Dosage Form 2015 – 2021(USD Billion)
25. Latin America Antifungal Drug Market Revenue, By Drug Type – 2021 (USD Billion)
26. Latin America Antifungal Drug Market Revenue, By Therapeutic Indication – 2021 (USD Billion)
27. Latin America Antifungal Drug Market Revenue, By Dosage Form – 2021 (USD Billion)
28. Brazil Antifungal Drug Market Revenue, By Drug Type – 2021 (USD Billion)
29. Brazil Antifungal Drug Market Revenue, By Therapeutic Indication – 2021 (USD Billion)
30. Brazil Antifungal Drug Market Revenue, By Dosage Form – 2021 (USD Billion)
31. Middle East And Africa Antifungal Drug Market Revenue, By Drug Type – 2021 (USD Billion)
32. Middle East And Africa Antifungal Drug Market Revenue, By Therapeutic Indication – 2021 (USD Billion)
33. Middle East And Africa Antifungal Drug Market Revenue, By Dosage Form – 2021 (USD Billion)

* Indicates required field.

Your Name*

Your Email*

Telephone Number*

Name of company*

Country Name*

How can we help you?

Prove You are Human*

captcha
Enter Capcha Image Properly



Share this Post

Related Posts

Checking...

Ouch! There was a server error.
Retry »

Sending message...

Enquiry Form

Fill in the form below and we will be in touch soon

Create Account



Log In Your Account